Full committee hearing on Medicaid drug reimbursements : are CMS cuts bad medicine for small businesses and beneficiaries? /

Medicaid Outpatient Prescription Drugs : Second Quarter 2008 Federal Upper Limit for Reimbursement Compared with Average Retail Pharmacy Acquisition Costs.
Published: (2009)

Medicare Part D, prescription drug benefit : increasing use and access of affordable prescription drugs : a report of the Special Committee on Aging, United States Senate.
Published: (2014)

Medicaid's reimbursements to pharmacies for prescription drugs.
by: Anderson, Todd
Published: (2004)

Department of Health and Human Services, Centers for Medicare and Medicaid Services : Medicaid program : time limitation on price recalculations and recordkeeping requirements under the drug rebate program.
by: Wannisky, Kathleen E.
Published: (2003)

States' collection of offset and supplemental Medicaid rebates.
Published: (2014)

Medicare Part B drugs : CMS data source for setting payments is practical but concerns remain : testimony before the Subcommittee on Health, Committee on Ways and Means, House of Representatives /
by: Steinwald, Bruce
Published: (2006)

Medicare : comments on CMS proposed 2006 rates for specified covered outpatient drugs and radiopharmaceuticals used in hospitals.
by: Steinwald, Bruce
Published: (2005)

Medicare : comments on CMS proposed 2006 rates for specified covered outpatient drugs and radiopharmaceuticals used in hospitals.
by: Steinwald, Bruce
Published: (2005)

Comparing Medicare and Medicaid Drug Pricing : Apples, Oranges and "Windfalls".
Published: (2008)

Medicare hospital pharmaceuticals : survey shows price variation and highlights data collection lessons and outpatient rate-setting challenges for CMS : report to congressional committees.
Published: (2006)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

GAO : Medicare's Communications to Beneficiaries of the Prescription Drug Benefit Could Be Improved, Fact Sheet.
Published: (2006)

Medicaid drug pricing in state maximum allowable cost programs.
Published: (2013)

Missouri claimed unallowable federal reimbursement for some Medicaid physician-administered drugs.
Published: (2015)

Medicaid prescription drugs : CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs : report to congressional requesters.
Published: (2013)

Compounded drugs under Medicare Part B : payment and oversight.
Published: (2014)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Medicare : CMS's implementation and oversight of the Medicare Prescription Drug Discount Card and Transitional Assistance Program.
by: Kanof, Marjorie E.
Published: (2005)

Medicare : CMS's implementation and oversight of the Medicare Prescription Drug Discount Card and Transitional Assistance Program.
by: Kanof, Marjorie E.
Published: (2005)

Medicare Part D coverage gap : discount program effects and brand-name drug price trends : report to congressional requesters.
Published: (2012)

Medicare Part D : Some Plan Sponsors Have Not Completely Implemented Fraud and Abuse Programs, and CMS Oversight Has Been Limited.
Published: (2008)

Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /
by: Dicken, John E.
Published: (2023)

Department of Health and Human Services, Centers for Medicare and Medicaid Services : Medicare program : Medicare-endorsed prescription drug card assistance initiative.
by: Wannisky, Kathleen E.
Published: (2002)

Authorized generic drugs : short-term effects and long-term impact.
Published: (2011)

Department of Health and Human Services, Centers for Medicare and Medicaid : Medicare program : Medicare prescription drug discount card.
by: Wannisky, Kathleen E.
Published: (2003)

Prescription drugs : comparison of DOD, Medicaid, and Medicare Part D retail reimbursement prices : report to the Ranking Member, Committee on Homeland Security and Governmental Affairs, U.S. Senate.
Published: (2014)

Reimbursement and access to prescription drugs under Medicare part B : hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Seventh Congress, second session, March 14, 2002.
Published: (2002)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Medicare Part D : Plan Sponsors' Processing and CMS Monitoring of Drug Coverage Requests Could Be Improved.
Published: (2008)

Drug pricing : research on savings from generic drug use /
by: Dicken, John E.
Published: (2012)

Medicare Part D Prescription Drug Coverage : Federal Oversight of Reported Price Concessions Data.
Published: (2008)

Expanding the use of generic drugs.
Published: (2010)

The impact of high-priced generic drugs on Medicare and Medicaid.
Published: (1998)

Medicaid's Reimbursements to Pharmacies for Prescription Drugs : CBO Paper /
Published: (2004)

Monitoring CMS' vital signs : implementation of the Medicare prescription drug benefit : hearing before the Oversight of Government Management, the Federal Workforce and the District of Columbia Subcommittee of the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Ninth Congress, first session, April 5, 2005.
Published: (2006)